FDA Inspection 874298 — Amphastar Nanjing Pharmaceuticals Inc
The FDA completed an inspection of Amphastar Nanjing Pharmaceuticals Inc on April 4, 2014 in Nanjing. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- April 4, 2014
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Nanjing (China)